Published in Br J Pharmacol on May 01, 1987
Specific pharmacology of calcium in myocardium, cardiac pacemakers, and vascular smooth muscle. Annu Rev Pharmacol Toxicol (1977) 7.32
Comparative pharmacology of calcium antagonists: nifedipine, verapamil and diltiazem. Am J Cardiol (1980) 3.14
Effects of nifedipine on myocardial perfusion and ischemic injury in dogs. Circ Res (1978) 1.67
Protective effect of pretreatment with verapamil, nifedipine and propranolol on mitochondrial function in the ischemic and reperfused myocardium. Am J Cardiol (1980) 1.54
Effect of nitrates and other coronary dilators on large and small coronary vessels: an hypothesis for the mechanism of action of nitrates. J Pharmacol Exp Ther (1969) 1.53
Therapeutic implications of slow-channel blockade in cardiocirculatory disorders. Circulation (1980) 1.26
Differential cardiovascular effects of calcium channel blocking agents: potential mechanisms. Am J Cardiol (1982) 1.13
The effects of nifedipine on acute experimental myocardial ischemia and infarction in dogs. Circ Res (1979) 1.13
Effects of calcium channel blocking agents on reperfusion arrhythmias. Am Heart J (1982) 1.05
The pathophysiology of malignant ventricular arrhythmias during acute myocardial ischemia. Circulation (1974) 1.03
Relationships between the severity of myocardial ischaemia, reperfusion-induced ventricular fibrillation, and the late administration of dazmegrel or nifedipine. J Cardiovasc Pharmacol (1985) 0.98
Reflex chronotropic and inotropic effects of calcium channel-blocking agents in conscious dogs. Diltiazem, verapamil, and nifedipine compared. Circ Res (1983) 0.97
Variable effect of nifedipine on myocardial blood flow at three grades of coronary occlusion in the dog. Circ Res (1981) 0.96
Antiarrhythmic and hemodynamic effects of calcium channel blocking agents during coronary arterial reperfusion. Comparative effects of verapamil and nifedipine. Am J Cardiol (1981) 0.96
Comparison of two dihydropyridine calcium antagonists on coronary collateral blood flow in acute myocardial ischemia. J Pharmacol Exp Ther (1981) 0.94
Acute coronary artery occlusion-reperfusion arrhythmias in pigs: antiarrhythmic and antifibrillatory evaluation of verapamil, nifedipine, prenylamine and propranolol. Eur J Pharmacol (1984) 0.86
Protective effect of early and late treatment with nifedipine during myocardial infarction in the conscious dog. Circulation (1984) 0.85
Comparative effects of a new nicotinamide nitrate derivative, nicorandil (SG 75), with nifedipine and nitroglycerin on true collateral blood flow following an acute coronary occlusion in dogs. J Cardiovasc Pharmacol (1984) 0.85
Effect of adrenergic activation on collateral coronary blood flow. Jpn Heart J (1974) 0.84
Effects of nicorandil, a new antianginal agent, and nifedipine on collateral blood flow in a chronic coronary occlusion model. J Pharmacol Exp Ther (1984) 0.83
Myocardial perfusion distal to an acute or chronic coronary artery occlusion: effects of diltiazem and nifedipine. J Pharmacol Exp Ther (1982) 0.82
Comparative effects of two slow channel calcium entry blockers, FR 34235 and nifedipine, on true coronary collateral blood flow. J Cardiovasc Pharmacol (1984) 0.81
Inotropic and chronotropic effects of vasodilators. J Pharmacol Exp Ther (1982) 0.80
Importance of myocardial blood flow changes in the protective action of diltiazem in a new model of myocardial ischaemia. Br J Pharmacol (1985) 0.78
Comparative effects of nitroglycerin and nifedipine on myocardial blood flow and contraction during flow-limiting coronary stenosis in the dog. Am J Cardiol (1982) 0.78
Ca-blockers and peripheral circulation--physiological viewpoints. Acta Pharmacol Toxicol (Copenh) (1978) 0.76
Antifibrillatory action. J Physiol (1962) 3.36
Protective effects of preconditioning of the ischaemic myocardium involve cyclo-oxygenase products. Cardiovasc Res (1990) 2.51
Antiarrhythmic effects of preconditioning in anaesthetised dogs and rats. Cardiovasc Res (1992) 1.86
Preconditioning of the ischaemic myocardium; involvement of the L-arginine nitric oxide pathway. Br J Pharmacol (1992) 1.71
Naloxone inhibits early arrhythmias resulting from acute coronary ligation. Br J Pharmacol (1982) 1.53
[Significant increase of pectus excavatum cases in Tata between 1990 and 1992]. Orv Hetil (1998) 1.38
Antiarrhythmic actions of meptazinol, a partial agonist at opiate receptors, in acute myocardial ischaemia. Br J Pharmacol (1983) 1.21
Local intracoronary infusions of bradykinin profoundly reduce the severity of ischaemia-induced arrhythmias in anaesthetized dogs. Br J Pharmacol (1991) 1.21
Effect of non-steroid anti-inflammatory drugs in experimental myocardial infarction in rats. Eur J Pharmacol (1981) 1.20
Effect of adenosine on sinoatrial and ventricular automaticity of the guinea pig. Naunyn Schmiedebergs Arch Pharmacol (1980) 1.16
The effects of prolonged oral administration of a new antidysrhythmic drug (Org 6001) on coronary artery ligation dysrhythmias in conscious and anesthetized rats. J Cardiovasc Pharmacol (1980) 1.14
Transient ischaemia induced by rapid cardiac pacing results in myocardial preconditioning. Cardiovasc Res (1991) 1.12
Effect of the blood supply to the normal noninfarcted myocardium on the incidence and severity of early post-occlusion arrhythmias in dogs. Basic Res Cardiol (1987) 1.10
The local intracoronary administration of methylene blue prevents the pronounced antiarrhythmic effect of ischaemic preconditioning. Br J Pharmacol (1992) 1.07
Nitroglycerin and dipyridamole on cardiac metabolism and dynamics in a new experimental model of angina pectoris. J Pharmacol Exp Ther (1976) 1.06
Coronary artery ligation, early arrhythmias, and determination of the ischemic area in conscious rats. J Pharmacol Methods (1983) 1.01
Prevention by an inhibitor of the L-arginine-nitric oxide pathway of the antiarrhythmic effects of bradykinin in anaesthetized dogs. Br J Pharmacol (1993) 1.01
Cardiovascular effects of conventional sulfonylureas and glimepiride. Horm Metab Res (1996) 0.95
The possible role of mast cells in pigmented nevi. Arch Dermatol Forsch (1974) 0.93
Are ATP sensitive potassium channels involved in the pronounced antiarrhythmic effects of preconditioning? Cardiovasc Res (1993) 0.91
Repeated cardiac pacing extends the time during which canine hearts are protected against ischaemia-induced arrhythmias: role of nitric oxide. J Mol Cell Cardiol (1999) 0.90
The possible mechanism of protection induced by dexamethasone against sudden death due to coronary ligation in conscious rats. Br J Pharmacol (1983) 0.90
Effect of BN 52021, a specific PAF-acether antagonist, on cardiac anaphylaxis in Langendorff hearts isolated from passively sensitized guinea-pigs. Eur J Pharmacol (1986) 0.89
Effect of actinomycin D and cycloheximide on experimental myocardial infarction in rats. Eur J Pharmacol (1982) 0.88
Pacing-induced delayed protection against arrhythmias is attenuated by aminoguanidine, an inhibitor of nitric oxide synthase. Br J Pharmacol (1999) 0.88
Proceedings: Function and metabolism of guinea pig atria incubated with various fatty acids under special consideration of arachidonic acid as a precursor of prostaglandins. Naunyn Schmiedebergs Arch Pharmacol (1975) 0.87
7-oxo-PgI2 induced late appearing and long-lasting electrophysiological changes in the heart in situ of the rabbit, guinea-pig, dog and cat. J Mol Cell Cardiol (1989) 0.86
The effect of beta-adrenoceptor blocking drugs on free fatty acid and glucose utilization of the isolated canine heart with normal and restricted flow in the presence and absence of noradrenaline. Acta Biol Med Ger (1978) 0.85
Protective effect of lidocaine against ischemia and reperfusion-induced arrhythmias and shifts of myocardial sodium, potassium, and calcium content. J Cardiovasc Pharmacol (1988) 0.85
Isosorbide-2-mononitrate reduces the consequences of myocardial ischaemia, including arrhythmia severity: implications for preconditioning. Cardiovasc Drugs Ther (2000) 0.85
Peroxynitrite decreases arrhythmias induced by ischaemia reperfusion in anaesthetized dogs, without involving mitochondrial KATP channels. Br J Pharmacol (2008) 0.84
[Experimental and finite-element models for the assessment of mandibular deformation under mechanical loading]. Mund Kiefer Gesichtschir (2000) 0.83
Pacing and reperfusion induced arrhythmias: protection by slow heart rate in the rat heart. Cardiovasc Res (1988) 0.83
Antiarrhythmic compounds. Prog Drug Res (1968) 0.83
Haemodynamic factors influencing myocardial ischaemia in a canine model of coronary artery stenosis: the effects of nitroglycerine. Br J Pharmacol (1983) 0.83
[On the testing of external corticoid with the Rebuck test]. Med Klin (1968) 0.83
The arrhythmogenic action of sympathomimetic amines. Eur J Pharmacol (1968) 0.82
Characteristics of the human skin bradykinin-destroying enzyme. J Med (1971) 0.82
Metoprolol reduces reperfusion-induced fibrillation in the isolated rat heart: protection is secondary to bradycardia. J Cardiovasc Pharmacol (1987) 0.82
Protective effects on verapamil and diltiazem against inorganic phosphate induced impairment of oxidative phosphorylation of isolated heart mitochondria. Biochem Pharmacol (1981) 0.82
Effect of arterial hypoxia on the susceptibility to arrhythmia of the heart. Acta Physiol Acad Sci Hung (1967) 0.81
Wound healing and fibrinolytic activity. Vasa (1973) 0.81
Effect of dietary sunflower seed oil on the severity of reperfusion-induced arrhythmias in anesthetized rats. J Cardiovasc Pharmacol (1992) 0.81
Atrial natriuretic peptide reduces the severe consequences of coronary artery occlusion in anaesthetized dogs. Cardiovasc Drugs Ther (2000) 0.81
Delayed protection of the heart against ischaemia. Trends Pharmacol Sci (1995) 0.81
Analysis of the mechanism of adrenergic actions on ventricular vulnerability. Eur J Pharmacol (1968) 0.80
On the possible role of adenosine in the hypoxia-induced alterations of the electrical and mechanical activity of the atrial myocardium. Arch Int Pharmacodyn Ther (1979) 0.80
Assay of antianginal drugs by relieving pituitrin induced coronary vasoconstriction in the intact unanaesthetized animal. Arch Int Pharmacodyn Ther (1966) 0.80
Possible involvement of platelet activating factor in anaphylaxis of passively sensitised, isolated guinea pig hearts. Cardiovasc Res (1989) 0.80
Moderate stress by cardiac pacing may induce both short term and long term cardioprotection. Cardiovasc Res (1993) 0.80
On the 7-oxo-PgI2 induced lasting protection against ouabain arrhythmias in anesthetized guinea pigs. Biomed Biochim Acta (1988) 0.80
Drug-induced augmentation of coronary flow in vessels with maximum ischemic dilatation. Arch Int Pharmacodyn Ther (1976) 0.79
Increased activity of sarcolemmal (Na+K+)-ATPase is involved in the late cardioprotective action of 7-oxo-prostacyclin. Cardioscience (1991) 0.79
Electron microscopic investigation on the local cellular reaction to primary malignant melanoma. Dermatologica (1981) 0.79
Alterations of the clinically noninvolved skin in patients with malignant melanoma. An electron microscopic study before and after repeated application of BCG. Dermatologica (1978) 0.79
Electrophysiological changes induced by lysophosphatidylcholine, an ischaemic phospholipid catabolite, in rabbit atrial and ventricular cardiac cells. Acta Physiol Hung (1992) 0.79
The effects of metoprolol and dazmegrel, alone and in combination, on arrhythmias induced by coronary artery occlusion in conscious rats. Br J Pharmacol (1985) 0.79
Influence of stretch and dynamic functional state of the myocardium on tendency of the heart to arrhythmia. Acta Physiol Acad Sci Hung (1967) 0.79
Fine structure and x-ray microanalysis of melanosomes in pigmented nevi and melanomas. Arch Dermatol Forsch (1975) 0.79
Some cardiac metabolic and haemodynamic alterations due to adrenergic beta-receptor blockade. Acta Biol Med Ger (1972) 0.79
The effects of arachidonic acid in isolated atria of guinea pigs. Eur J Pharmacol (1977) 0.79
Delayed antiischemic effect of prostaglandin I2 and of a new stable prostaglandin I2 analogue, 7-oxo-prostacyclin-Na, in experimental model angina in dogs. Adv Myocardiol (1985) 0.79
Experimental myocardial infarction in adjuvant arthritis rats. J Cardiovasc Pharmacol (1982) 0.78
Prevention by 7-oxo-prostacyclin of the calcium paradox in rat heart: role of the sarcolemmal (Na,K)-ATPase. Mol Cell Biochem (1997) 0.78
Suppression of reperfusion induced arrhythmias in the isolated rat heart: pretreatment with 7-oxo prostacyclin in vivo. Cardiovasc Res (1993) 0.78
Importance of haemodynamic, metabolic and electrocardiographic alterations in the detection of coronary failure. Acta Med Acad Sci Hung (1975) 0.78
On the mechanism and possible therapeutic application of delayed adaptation of the heart to stress situations. Mol Cell Biochem (1996) 0.78
Short incubation with 7-oxo-prostacyclin induces long lasting prolongation of repolarisation time and effective refractory period in rabbit papillary muscle preparation. Cardiovasc Res (1990) 0.78
On the late antiischaemic action of the stable PgI2 analogue: 7-oxo-PgI2-Na and its possible mode of action. Biomed Biochim Acta (1984) 0.78
On the nature and molecular basis of prostacyclin induced late cardiac changes. Biomed Biochim Acta (1988) 0.78
Cardiovascular effects of the calcium sensitizer, levosimendan, in heart failure induced by rapid pacing in the presence of aortic constriction. Br J Pharmacol (1995) 0.78
Importance of myocardial blood flow changes in the protective action of diltiazem in a new model of myocardial ischaemia. Br J Pharmacol (1985) 0.78
[Structural variants of intracellular flagella and centrioles in nevus cells]. Z Hautkr (1975) 0.78
Modification by bradykinin B2 receptor blockade of protection by pacing against ischaemia-induced arrhythmias. Eur J Pharmacol (1997) 0.78
Long lasting anti-adrenergic effect of 7-oxo-prostacyclin in the heart: a cycloheximide sensitive increase of phosphodiesterase isoform I and IV activities. Mol Cell Biochem (1994) 0.78
Evaluation of the effect of Lake Hévíz thermal mineral water in patients with osteoarthritis of the knee: a randomized, controlled, single-blind, follow-up study. Eur J Phys Rehabil Med (2014) 0.78
7-oxo-PGI2 induced late protective action from arrhythmias due to local myocardial ischemia. Bratisl Lek Listy (1991) 0.77
Cardiac effects of prostaglandins E2 and F2alpha. Arch Int Pharmacodyn Ther (1974) 0.77
Cardiac actions of arachidonic acid. Acta Biol Med Ger (1976) 0.77
Repeated biopsies in evaluation of therapeutic effects in prostate carcinoma. Prostate (2001) 0.77
Potentiation of the myocardial actions of adenosine in the presence of coformycin, a specific inhibitor of adenosine deaminase. Arch Int Pharmacodyn Ther (1982) 0.77
Effects of octanoate on the electrical activity of Purkinje fibres. Experientia (1974) 0.77
Comparison of two calcium antagonists, verapamil and fendiline, in an experimental model of myocardial ischaemia mimicking classical angina on effort. Br J Pharmacol (1983) 0.77
Protective effect of 7-oxo-prostacyclin on myocardial function and metabolism during postischemic reperfusion and calcium paradox. Basic Res Cardiol (1992) 0.77